EX-16.1 2 f161.htm LETTER FROM HEIN & ASSOCIATES, LLP DATED NOVEMBER 22, 2017 Converted by EDGARwiz

EXHIBIT 16.1



November 22, 2017



Securities and Exchange Commission

Washington, D.C. 20549



Commissioners:



We have read IASO BioMed’s statements included under Item 4.01 of its Form 8-K filed on November 22, 2017 and we agree with such statements concerning our firm.



/s/ Hein & Associates LLP


Hein & Associates LLP